Stay updated on Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, indicating a minor site/template update.
    Difference
    0.1%
    Check dated 2026-05-15T15:29:47.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision label was updated from **v3.5.2** to **v3.5.3**, indicating a newer site/application version for the same study record.
    Difference
    0.1%
    Check dated 2026-04-24T05:58:40.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:56.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:53:17.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:53:29.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added site navigation/footer elements for Moffitt Clinical Trials, the sponsoring institution, Helpful Links, and access to drug/device information and study documents.
    Difference
    0.3%
    Check dated 2026-02-25T18:25:57.000Z thumbnail image

Stay in the know with updates to Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.